Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
November 07, 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
November 03, 2023 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
October 19, 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4
September 29, 2023 09:25 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase
September 19, 2023 17:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference
September 06, 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports First Quarter 2023 Financial Results
May 05, 2023 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2023 total revenue of $5.0 million, representing growth of 21%, compared to first quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...
Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing
May 04, 2023 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023
April 13, 2023 16:05 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
March 03, 2023 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 million,...